Ascend (Drug Discovery) logo

Ascend (Drug Discovery)

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
13
Total Funding
$194.3M
Investors
13 investors across all rounds
4C
4BIO Capital
A
Abingworth
A
Ajinomoto
CC
Cathay Capital
CH
Cathay Health

+8 more investors

Sign in to view all

Explore More Data
Detailed analysis for Ascend (Drug Discovery)

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Ascend (Drug Discovery) Leadership & Investors

Ascend (Drug Discovery) is led by a team of experienced leaders. The company has attracted investment from 13 institutional and strategic investors.

Who Has Invested in Ascend (Drug Discovery)?

Ascend (Drug Discovery) has raised $194.3M from 13 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Ascend (Drug Discovery) shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.